click below
click below
Normal Size Small Size show me how
Pain/Heme/Onc 3
Pain, Hematology, and Oncology 3
| Generic | Brand | Pharmacologic Category | Common Indications | Key Side Effect | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| methotrexate (PO) | Trexall | Antimetabolite (folic acid antagonist) | Rheumatoid arthritis, Crohn’s Disease, psoriasis, various hematologic and solid tumors | stomatitis, diarrhea, nausea, vomiting, thrombocytopenia, leukopenia, increased hepatic transaminases, pulmonary fibrosis (rare) | serious toxic rxns,' may cause fetal death or abnormalities; severe bone marrow suppression, anemia and toxicity w/ NSAIDS; cause hepatotoxicity, induce lung disease, pneumonitis | folic acid supplementation may be taken during use to reduce hematologic, gastrointestinal, and hepatic side effects |
| anastrozole (PO) | Arimidex | Aromatase inhibitor | Hormone receptor-positive breast cancer | fatigue, rash, flushing, hot flashes, arthralgia, nausea, vomiting, hypertension, peripheral edema, osteoporosis | cardiovascular side effects (i.e., hypercholesterolemia, CAD); fetal toxicity (CI in pregnancy) | |
| cisplatin (IV, IT, IP) | Kemoplat | Antineoplastic agent, platinum based compound | Advanced bladder, ovarian, and testicular cancer; various cancers | bone marrow suppression, nausea, vomiting, nephrotoxicity, neurotoxicity, ototoxicity | may cause severe myelosuppression, nausea and vomiting, renal toxicity, and dose-related neuropathy | |
| doxorubicin (IV) | Adriamycin | Antineoplastic agent, anthracycline | Adjuvant therapy for breast cancer, various cancers | cardiomyopathy, alopecia, nausea, vomiting, bone marrow suppression | may cause cardiomyopathy, myelosuppression, secondary malignancies; extravasation can result in severe local tissue injury and necrosis | may cause red discoloration of urine, tears, sweat, and saliva |
| pembrolizumab (IV) | Keytruda | Antineoplastic agent, monoclonal antibody | Various cancers | peripheral edema, pruritus, skin rash, endocrine and metabolic abnormalities, constipation, diarrhea, nausea, vomiting, hematuria, anemia, increased liver enzymes, fatigue, musculoskeletal pain, increased serum creatinine, dyspnea | ||
| tamoxifen (PO) | Soltamox | Selective estrogen receptor modulator (SERM) | Hormone receptor-positive breast cancer | hot flashes/night sweats, vaginal bleeding/discharge, decreased bone density (in premenopausal females) | increased risk for uterine or endometrial cancer and thromboembolic events | contraception should be used in premenopausal females due to teratogenicity of the drug; do not use with warfarin or history DVT/PE |